Literature DB >> 1699919

Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.

T Suzuki1, T Morio, S Tohda, K Nagata, Y Yamashita, Y Imai, N Aoki, K Hirashima, N Nara.   

Abstract

The effects of recombinant human interleukin-6 (rh IL-6), which has homology with rh granulocyte colony-stimulating factor (rh G-CSF) at the amino acid sequence level, and rh G-CSF on normal human bone marrow cells, fresh leukemic blast progenitors from 16 acute myeloblastic leukemia (AML) patients, and G-CSF-dependent human AML cell line (OCI/AML 1a) were investigated. rh G-CSF stimulated the proliferation of leukemic blast progenitors from 13 out of 16 AML patients tested. rh IL-6 stimulated the proliferation of blasts from eight AML patients and enhanced the G-CSF-dependent proliferation of the fresh AML blasts from two out of eight patients tested. On the other hand, rh IL-6 suppressed the blast colony formation from two AML patients and OCI/AML 1a cells and also reduced the G-CSF-dependent proliferation of the blast progenitors from one of the two patients and the cell line, rh IL-6 had no effect on the colony formation of normal granulocyte-macrophage colony-forming units (CFU-GM) with or without rh G-CSF. Differentiation-induction by rh IL-6 was not observed in the fresh AML blasts but was observed in OCI/AML 1a. The effect of IL-6 on the blast colony formation and G-CSF-dependent blast cell growth was complicated and heterogenous among the AML cases; IL-6 stimulated blast colony formation in some cases and suppressed it in others. The heterogeneity of the response was supposed to be derived from the heterogeneity of the characteristics of AML cells. Although G-CSF simply stimulated the blast colony formation, IL-6 had a bimodulatory effect on the proliferation of leukemic blast progenitors from AML patients. IL-6 might be involved in the regulation of the proliferation of AML cells in vivo as well as in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699919      PMCID: PMC5917970          DOI: 10.1111/j.1349-7006.1990.tb03335.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  19 in total

Review 1.  Stem cell renewal and differentiation in acute myeloblastic leukaemia.

Authors:  E A McCulloch; M D Minden; J Miyauchi; C A Kelleher; C Wang
Journal:  J Cell Sci Suppl       Date:  1988

2.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

3.  Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia.

Authors:  I Murohashi; S Tohda; T Suzuki; K Nagata; Y Yamashita; N Nara
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

4.  Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line.

Authors:  Y Yamashita; N Nara; N Aoki
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

5.  Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia.

Authors:  M D Minden; R N Buick; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

6.  Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons.

Authors:  M Beran; K B McCredie; M J Keating; J U Gutterman
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia.

Authors:  N Nara; E A McCulloch
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

8.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

9.  Effects of recombinant G-CSF and GM-CSF on the growth in methylcellulose and suspension of the blast cells in acute myeloblastic leukemia.

Authors:  I Murohashi; K Nagata; T Suzuki; Y Maruyama; N Nara
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

10.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor.

Authors:  T Shirai; H Yamaguchi; H Ito; C W Todd; R B Wallace
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

View more
  5 in total

Review 1.  G-CSF: status quo and new indications.

Authors:  F Herrmann
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.

Authors:  K Akashi; T Shibuya; M Harada; Y Takamatsu; N Uike; T Eto; Y Niho
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 3.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Antibiotic and glucocorticoid-induced recapitulated hematological remission in acute myeloid leukemia: A case report and review of literature.

Authors:  Xiao-Yun Sun; Xiao-Dong Yang; Xiao-Qiu Yang; Bo Ju; Nuan-Nuan Xiu; Jia Xu; Xi-Chen Zhao
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

Review 5.  The cytokine network in acute myeloid leukemia.

Authors:  Michela Luciano; Peter W Krenn; Jutta Horejs-Hoeck
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.